FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes Covid-19 in Patients
FDA’s Stephen M. Hahn, MD, and Jeff Shuren, MD, JD, discuss the agency’s first EUA for a covid-19 antigen test.
Read MorePosted by Steve Halasey | May 11, 2020 | Covid 19, Uncategorized |
FDA’s Stephen M. Hahn, MD, and Jeff Shuren, MD, JD, discuss the agency’s first EUA for a covid-19 antigen test.
Read MorePosted by Laurie Bonner | May 11, 2020 | Covid 19, Uncategorized |
The library is adapted for screening with phage display and strives to meet the rising demand for effective antibodies for a broad range of applications.
Read MorePosted by Laurie Bonner | May 8, 2020 | Covid 19 |
The company’s latest covid-19 products include a protein-coated RNA process control, and an in vitro diagnostics control with pooled gene targets.
Read MorePosted by Laurie Bonner | May 8, 2020 | Covid 19 |
The new solution is designed to enable laboratories to enter biospecimens into a biobank and rapidly begin conducting covid-19-related testing and research.
Read MorePosted by Laurie Bonner | May 7, 2020 | Covid 19 |
Microproof SARS-CoV-2 screening/identification kits run on many commonly used real-time PCR instruments. The test returns results in less than 1.5 hours.
Read More